Tevogen Statistics
Total Valuation
Tevogen has a market cap or net worth of $395.84 million. The enterprise value is $406.11 million.
Important Dates
The last earnings date was Monday, November 16, 2026, after market close.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Tevogen has 68.68 million shares outstanding. The number of shares has increased by 0.84% in one year.
| Current Share Class | 68.68M |
| Shares Outstanding | 68.68M |
| Shares Change (YoY) | +0.84% |
| Shares Change (QoQ) | +7.01% |
| Owned by Insiders (%) | 92.75% |
| Owned by Institutions (%) | 0.09% |
| Float | 4.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -66.36 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -588.78% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 790.15% |
| Weighted Average Cost of Capital (WACC) | 5.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.01% in the last 52 weeks. The beta is 0.23, so Tevogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -72.01% |
| 50-Day Moving Average | 6.61 |
| 200-Day Moving Average | 7.47 |
| Relative Strength Index (RSI) | 51.88 |
| Average Volume (20 Days) | 8,201 |
Short Selling Information
The latest short interest is 54,853, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 54,853 |
| Short Previous Month | 55,420 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 1.10% |
| Short Ratio (days to cover) | 6.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.58M |
| Pretax Income | -22.89M |
| Net Income | -23.58M |
| EBITDA | -22.44M |
| EBIT | -22.58M |
| Earnings Per Share (EPS) | -$7.00 |
Full Income Statement Balance Sheet
The company has $144,713 in cash and $10.41 million in debt, with a net cash position of -$10.27 million or -$0.15 per share.
| Cash & Cash Equivalents | 144,713 |
| Total Debt | 10.41M |
| Net Cash | -10.27M |
| Net Cash Per Share | -$0.15 |
| Equity (Book Value) | -11.29M |
| Book Value Per Share | -1.33 |
| Working Capital | -5.53M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$9.88 million and capital expenditures -$64,439, giving a free cash flow of -$9.94 million.
| Operating Cash Flow | -9.88M |
| Capital Expenditures | -64,439 |
| Depreciation & Amortization | 132,830 |
| Net Borrowing | 3.00M |
| Free Cash Flow | -9.94M |
| FCF Per Share | -$0.14 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Tevogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.84% |
| Shareholder Yield | -0.84% |
| Earnings Yield | -121.45% |
| FCF Yield | -2.30% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on March 6, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | Mar 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |